Paradigm Biocapital Advisors LP Q1 2024 Filing

Filed May 15, 2024

Portfolio Value

$2840.8T

Holdings

34

Report Date

Q1 2024

Filing Type

13F-HR

All Holdings (34 positions)

#StockSharesValue% PortfolioType
1
NUVLNUVALENT INC
4,177,830$313.7T11.04%
2
ACLXARCELLX INC
3,818,095$265.5T9.35%
3
ARGXARGENX SE
552,120$217.4T7.65%
4
IRONDISC MEDICINE INC
2,389,902$148.8T5.24%
5
CRNXCRINETICS PHARMACEUTICALS IN
3,124,749$146.3T5.15%
6
SRPTSAREPTA THERAPEUTICS INC
1,078,346$139.6T4.91%
7
IMCRIMMUNOCORE HLDGS PLC
1,787,176$116.2T4.09%
8
LEGNLEGEND BIOTECH CORP
1,982,006$111.2T3.91%
9
ARVNARVINAS INC
2,614,935$107.9T3.80%
10
XENEXENON PHARMACEUTICALS INC
2,484,874$107.0T3.77%
11
TARSTARSUS PHARMACEUTICALS INC
2,863,406$104.1T3.66%
12
CERE1EURCEREVEL THERAPEUTICS HLDNG I
2,330,508$98.5T3.47%
13
RVMDREVOLUTION MEDICINES INC
2,914,975$93.9T3.31%
14
OLMAOLEMA PHARMACEUTICALS INC
7,903,600$89.5T3.15%
15
VRDNVIRIDIAN THERAPEUTICS INC
5,031,420$88.1T3.10%
16
PCVXVAXCYTE INC
1,239,995$84.7T2.98%
17
NVLSEURALPINE IMMUNE SCIENCES INC
2,121,163$84.1T2.96%
18
BCYCBICYCLE THERAPEUTICS PLC
3,246,759$80.8T2.85%
19
ASNDASCENDIS PHARMA A/S
507,952$76.8T2.70%
20
KURAKURA ONCOLOGY INC
3,135,387$66.9T2.35%
21
EWTXEDGEWISE THERAPEUTICS INC
2,446,373$44.6T1.57%
22
AUTLAUTOLUS THERAPEUTICS PLC
6,425,803$41.0T1.44%
23
YMABUSDY-MABS THERAPEUTICS INC
2,233,610$36.3T1.28%
24
IMTXIMMATICS N.V
2,818,908$29.6T1.04%
25
IMVTIMMUNOVANT INC
799,054$25.8T0.91%
26
CGEMCULLINAN ONCOLOGY INC
1,348,015$23.0T0.81%
27
APGEAPOGEE THERAPEUTICS INC
330,000$21.9T0.77%
28
CMPSCOMPASS PATHWAYS PLC
2,390,988$19.9T0.70%
29
VORVOR BIOPHARMA INC
6,457,293$15.3T0.54%
30
ZNTLZENTALIS PHARMACEUTICALS INC
944,917$14.9T0.52%
31
AGIOAGIOS PHARMACEUTICALS INC
400,000$11.7T0.41%
32
CRBUCARIBOU BIOSCIENCES INC
2,172,620$11.2T0.39%
33
CRGXCARGO THERAPEUTICS INC
147,959$3.3T0.12%
34
KYTXKYVERNA THERAPEUTICS INC
50,000$1.2T0.04%